BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 15190272)

  • 1. Thrombosis and cancer.
    Kakkar AK
    Hematol J; 2004; 5 Suppl 3():S20-3. PubMed ID: 15190272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism and cancer: prevention and therapy.
    Lee AY
    Vnitr Lek; 2006 Mar; 52 Suppl 1():127-8, 130-1. PubMed ID: 16637461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Venous thromboembolism in oncologic patients: guidelines for prevention and therapy and areas of uncertainty].
    Di Minno G; Tufano A
    Tumori; 2006; 92(6):suppl 1-15. PubMed ID: 17260505
    [No Abstract]   [Full Text] [Related]  

  • 4. Venous thromboembolism in cancer patients: expanding horizons.
    Bergqvist D
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():19-23. PubMed ID: 12232819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolic disease in cancer. Optimisation of the use of antithrombotic agents.
    Camps C; Juárez A; Iranzo V; Garde J; Blasco A; Sirera R
    Clin Transl Oncol; 2007 Mar; 9(3):161-71. PubMed ID: 17403627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment.
    Sutherland DE; Weitz IC; Liebman HA
    Am J Hematol; 2003 Jan; 72(1):43-52. PubMed ID: 12508268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Venous thromboembolism and cancer].
    Pavic M; Debourdeau P; Aletti M; Farge-Bancel D; Rousset H
    Rev Med Interne; 2006 Apr; 27(4):313-22. PubMed ID: 16414153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of low-molecular-weight heparins in the prevention and treatment of venous thromboembolism in cancer patients.
    Lee AY
    Curr Opin Pulm Med; 2003 Sep; 9(5):351-5. PubMed ID: 12904702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin and cancer].
    Lykke J
    Ugeskr Laeger; 2006 Dec; 168(50):4397-401. PubMed ID: 17217864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of cancer and thrombosis.
    Matzdorff AC; Green D
    Cancer Treat Res; 2009; 148():83-94. PubMed ID: 19377920
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood coagulation and cancer: thrombosis and survival, clinical relevance and impact. An introduction.
    Vestjens JH; Sassen S; Prins MH
    Pathophysiol Haemost Thromb; 2008; 36(3-4):113-21. PubMed ID: 19176984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Practice guidelines for the prevention of venous thromboembolism in elderly patients hospitalized in subacute care and rehabilitation facilities (short text). Association for the Promotion of Hospital Angiology].
    Bosson JL; Labarère J; Barrellier MT; Belmin J; Couturier P; Le Roux P; Sevestre MA;
    J Mal Vasc; 2003 Oct; 28(4):209-18. PubMed ID: 14618112
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin.
    Saccullo G; Malato A; Raso S; Santoro M; Zammit V; Casuccio A; Siragusa S
    Am J Hematol; 2012 Apr; 87(4):388-91. PubMed ID: 22374861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis in childhood cancer.
    Allen GA; Bhat R
    Cancer Treat Res; 2009; 148():223-42. PubMed ID: 19377927
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer and venous thromboembolism.
    Piccioli A; Falanga A; Baccaglini U; Marchetti M; Prandoni P
    Semin Thromb Hemost; 2006 Oct; 32(7):694-9. PubMed ID: 17024596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparins in the treatment of cancer-associated thrombosis: a new standard of care?
    Burris HA
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S3-16; quiz S41-2. PubMed ID: 16638456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J; Goodin S
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we optimise treatment of thrombosis?
    Levine MN
    Cancer Treat Rev; 2003 Jun; 29 Suppl 2():19-22. PubMed ID: 12887946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronicity of hypercoagulative state: a favourable evidence for postoperative prolongation of antithrombotic prophylaxis].
    Iturbe Hernández T; Cornudella Lacasa R; Moreno Chulilla JA; Gutiérrez Martín M
    Med Clin (Barc); 2003 Apr; 120(14):559. PubMed ID: 12724070
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
    Cunningham RS
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.